BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 579109)

  • 1. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation and some parameters that affect the galactosamine model of hepatitis in the rat.
    Pickering RW; James GW; Parker FL
    Arzneimittelforschung; 1975 Jun; 25(6):898-901. PubMed ID: 1174326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison between the morphologic changes in the livers of hamsters and rats after galactosamine treatment and their correlation with altered serum transaminase levels.
    Pickering RW
    Arzneimittelforschung; 1977; 27(9):1684-7. PubMed ID: 579138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine.
    Perings E; Brunner G; Vido I; Söling HD; Creutzfeldt W
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):130-4. PubMed ID: 4148023
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
    Pickering RW; Lynn James GW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of liver-RES on toxic liver damage due to galactosamine.
    Grün M; Liehr H; Grün W; Rasenack U; Brunswig D
    Acta Hepatogastroenterol (Stuttg); 1974 Feb; 21(1):5-15. PubMed ID: 4450963
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protecting action of aspartate on the hepatic changes induced by D-galactosamine.
    Fodor O; Schvartz M; Suciu A; Barbarino F; Duca S; Lezeu R
    Arzneimittelforschung; 1976; 26(5):855-8. PubMed ID: 183787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
    Schriewer H; Rausen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:159. PubMed ID: 4740687
    [No Abstract]   [Full Text] [Related]  

  • 13. Ongoing hepatocellular regeneration and resiliency toward galactosamine hepatotoxicity.
    Abdul-Hussain SK; Mehendale HM
    Arch Toxicol; 1992; 66(10):729-42. PubMed ID: 1290405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatobiliary clearance of labelled mebrofenin in normal and D-galactosamine HCl-induced hepatitis rats and the protective effect of turmeric extract.
    Deshpande UR; Joseph LJ; Samuel AM
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):332-6. PubMed ID: 14723320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats.
    Lesch R; Reutter W; Keppler D; Decker K
    Exp Mol Pathol; 1970 Feb; 12(1):58-69. PubMed ID: 5418074
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antihepatotoxic influence of silymarin on galactosamine hepatitis in the rat].
    Meyer-Burg J
    Klin Wochenschr; 1972 Nov; 50(22):1062-3. PubMed ID: 4637662
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective role of prednisolone upon galactosamine-induced hepatitis in rats.
    Grases PJ; Reutter W; Lesch R
    G E N; 1972; 27(2):197-204. PubMed ID: 4201408
    [No Abstract]   [Full Text] [Related]  

  • 19. Dietary wheat gluten alleviates the elevation of serum transaminase activities in D-galactosamine-injected rats.
    Manabe A; Cheng CC; Egashira Y; Ohta T; Sanada H
    J Nutr Sci Vitaminol (Tokyo); 1996 Apr; 42(2):121-32. PubMed ID: 8780970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration.
    Record CO; Alberti KG; Williamson DH
    Biochem J; 1972 Nov; 130(1):37-44. PubMed ID: 4655444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.